Evidence map›Paper›PMID 33295867›Full record

ArticleMicrobial genomics2021

Genomic epidemiology of

Gerald Tegha, Emily J Ciccone, Robert Krysiak, James Kaphatika, Tarsizio Chikaonda, Isaac Ndhlovu, David van Duin, Irving Hoffman, Jonathan J Juliano, Jeremy Wang

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Prevalence of Extended-Spectrum β-Lactamase-ProducingAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. A nationwide survey of antimicrobial resistance ofJAC-antimicrobial resistance · 2024
    Article
  6. Article
  7. DiarrheagenicInternational journal of molecular sciences · 2024
    Article
  8. Article
  9. Observational
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Antimicrobial Resistance inFrontiers in medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Gerald TeghaUNC Project, Lilongwe, Malawi.
Emily J CicconeDivision of Infectious Diseases, School of Medicine, University of North Carolina, USA.
Robert KrysiakUNC Project, Lilongwe, Malawi.
James KaphatikaUNC Project, Lilongwe, Malawi.
Tarsizio ChikaondaUNC Project, Lilongwe, Malawi.
Isaac NdhlovuKamuzu Central Hospital, Lilongwe, Malawi.
David van DuinDivision of Infectious Diseases, School of Medicine, University of North Carolina, USA.
Irving HoffmanDivision of Infectious Diseases, School of Medicine, University of North Carolina, USA.
Jonathan J JulianoDivision of Infectious Diseases, School of Medicine, University of North Carolina, USA.
Jeremy WangDepartment of Genetics, School of Medicine, University of North Carolina, USA.
Kamuzu Central Hospital · MWUniversity of North Carolina at Chapel Hill · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
TRAINING IN RESPIRATORY AND ENVIRONMENTAL MEDICINET32HL007106 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BOUCHER, RICHARD CHARLES, DOERSCHUK, CLAIRE M · 1985 to 2021
$7.3M
Advanced sequencing as a novel diagnostic tool to discover strain-level variation and function of mucosal-adherent bacteria contributing to IBDK01DK119582 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WANG, JEREMY R · 2019 to 2023
$754k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS T32 HL007106NIDDK NIH HHS K01 DK119582
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a global threat, including in sub-Saharan Africa. However, little is known about the genetics of resistant bacteria in the region. In Malawi, there is growing concern about increasing rates of antimicrobial resistance to most empirically used antimicrobials. The highly drug resistant

Indexed as

Drug Resistance, Multiple, BacterialAdultEscherichia coliEscherichia coli InfectionsFeasibility StudiesFemaleHumansLongitudinal StudiesMalawiMaleMiddle AgedMultilocus Sequence TypingPhylogenyPlasmidsPrevalenceSequence Analysis, DNAAfricaantimicrobial resistanceEscherichia coliMalawimolecular epidemiologywhole genome sequencing

Identifiers

PMID33295867
PMCPMC8115906
OpenAlexW3110904928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.